The Quantellect read.As of Nov 19, 2026, 5 active firms cover Neuropace Inc: 5 rate it Buy or better, 0 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets are tightly clustered, $18.00 to $22.00, so the covering firms are broadly aligned. The average target of $20.00 sits 143% above the current $8.22. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.10 next quarter toward $-0.32 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS5 active firms
Buy
Strong Buy00%
Buy5100%
Neutral00%
Sell00%
Strong Sell00%
Based on 5 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$20.00
+143.3% upside
Average target across 3 active firms as of Nov 19, 2026 vs $8.22 current
Highest Target$22.00
Average Target$20.00
Lowest Target$18.00
Detailed analyst forecasts for NPCE
Showing 1–3 of 3 named analysts shown · 5 active firms in the rating projection
As of Nov 19, 2026, 5 of 5 active firms rate NPCE a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
NPCE EPS & revenue forecast
EPS · NEXT QUARTER
$-0.10
Range $-0.13 – $-0.04 · 6 analysts
Next period, 6 analysts expect Neuropace Inc to earn $-0.10 a share (range $-0.13 – $-0.04), versus — a year earlier. Full-year consensus is $-0.41, growing to $-0.32 the year after.
REVENUE · NEXT QUARTER
$25.1M
Range $23.9M – $27.0M · 6 analysts
Revenue is expected to reach $25.1M (range $23.9M – $27.0M). Full-year consensus is $91.3M, rising to $109.3M next year.
Top analysts covering Neuropace Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on NPCE.
#1
Anthony Petrone
Mizuho · Rank #121
Buy
$22.00+167.6% to target
Overall win rate
45%
+ Follow
#2
Sarah James
Cantor Fitzgerald · Rank #159
Buy
$12.00+46.0% to target
Overall win rate
37%
+ Follow
#3
Ross Osborn
Cantor Fitzgerald · Rank #238
Buy
$16.00+94.6% to target
Overall win rate
34%
+ Follow
#4
Yi Chen
HC Wainwright & Co. · Rank #350
Buy
$20.00+143.3% to target
Overall win rate
34%
+ Follow
#5
Frank Takkinen
Lake Street · Rank #514
Buy
$13.00+58.2% to target
Overall win rate
27%
+ Follow
NPCE stock forecast FAQ
What is NPCE's average 12-month price target?+
The 3 active firms with a live target average $20.00 for Neuropace Inc over the next 12 months, ranging from a $22.00 high to a $18.00 low, as of Nov 19, 2026.
Is NPCE stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 5 active firms as of Nov 19, 2026, 5 rate it Buy or Strong Buy, 0 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for NPCE?+
The Street-high target is $22.00 (Mizuho), and the Street-low is $18.00 (Keybanc). The average of all 3 active-firm targets is $20.00.
How many active Wall Street firms cover NPCE?+
5 active firms have a recognized rating on Neuropace Inc as of Nov 19, 2026, and 3 active firms carry a live 12-month price target.
Who is the most accurate analyst covering NPCE?+
Among analysts who currently cover NPCE, Anthony Petrone of Mizuho has the strongest overall Quantellect track record (Rank #121). Their current call is Buy with a $22.00 target.
What is Neuropace Inc's projected EPS for next quarter?+
The consensus estimate is $-0.10 per share (range $-0.13 – $-0.04) across 6 analysts. Full-year EPS is projected at $-0.41, rising to $-0.32 the following year.
How much revenue is Neuropace Inc expected to report next quarter?+
Consensus revenue is $25.1M (range $23.9M – $27.0M). Full-year revenue is projected at $91.3M, growing to $109.3M next year.
Have analysts been upgrading or downgrading NPCE lately?+
As of Nov 19, 2026, 5 of 5 active firms rate NPCE a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their NPCE calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.